Home › Stocks › Cytokinetics

Cytokinetics Incorporated (CYTK)

Nasdaq Global Select

$62.70

▲ +$0.75 (+1.21%)

Trade Cytokinetics (CYTK) with a $100K Funded Account

Q: How do I qualify to trade Cytokinetics Incorporated (CYTK) and what is the profit split?

You can start trader2B® FREE $100K evaluation with no upfront cost or credit card required. After meeting the performance requirements and passing the evaluation, you can receive a live funded account with a 50% profit split. Traders who want higher payout percentages can choose paid Funded Trader Pricing – ToroChallenge® Plans | trader2B® offering up to 95%–99% profit splits. Symbol availability depends on the eligible symbol list for each program.

Q: Why are some U.S. stocks not available to trade on trader2B®?

trader2B® limits its eligible symbol list based on liquidity, price, short-sale availability, risk, and overall market quality. Stocks with low trading volume, very low prices, wide bid-ask spreads, limited short availability, or elevated manipulation risk may be excluded from the FREE $100K ToroChallenge®. You can view the current list of approved stocks on the eligible symbol list

Q: What platforms can I use to trade CYTK with trader2B®?

trader2B® WebTrader: A fast, browser-based platform requiring zero software downloads. trader2B® Desktop: A high-performance downloadable application for Windows, macOS, and Linux, equipped with multi-monitor support, Level II data, and hotkey execution. trader2B® Mobile App: Mobile trading available on both iOS (App Store) and Android (Google Play) to monitor and manage open positions on the go. API Trading: Automated execution and custom algorithmic trading enabled via the optional trader2B® API add-on

Q: How much buying power do I get to trade CYTK?

Traders starting the FREE $100K ToroChallenge® are allocated up to $100,000 in intraday buying power to trade eligible U.S. equities, including Cytokinetics Incorporated (CYTK). For traders seeking greater capital scaling, our advanced paid tiers provide up to $250,000 in total buying power with flexible account reset options. You can compare all available capital allocations and upgrade paths directly on our plans page.

Trade CYTK and top U.S. stocks through trader2B^® FREE $100K Challenge. Pass and receive a live funded account after approval, with 50% of your trading profits.

FREE funded path profit split: 50% after qualification.

✓ 100% FREE

- No credit card

✓ U.S. Stocks

- Real market data*

✓ Profit Split

- 50% on FREE $100K account

✓ Trading Style

- Day Trading

100% FREE

No credit card

U.S. Stocks

Real market data*

Profit Split

50% on FREE $100K account

Trading Style

Day Trading

Start FREE $100k Challenge

Open $62.06

Previous Close $61.95

Day High $63.61

Day Low $62.06

Volume $309.09K

Market Cap $8.72B

Cytokinetics Financial Highlights

EPS -$6.54

Revenue $88.04M

Dividend $0.00

52 Week Low $35.22

52 Week High $88.31

200 MA $69.20

Latest Cytokinetics (CYTK) Stock News

Recent company and market developments from original news sources.

Cytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy GlobeNewswire·Oct 19, 2026 Outperform Recommendation Issued On CYTK By William Blair KlickAnalytics·Oct 16, 2026 Statement of changes in beneficial ownership of securities - Form 4 SEC Filings (All years)·Oct 13, 2026 Notice of proposed sale of securities pursuant to Rule 144 - Form 144 SEC Filings (All years)·Oct 13, 2026 Cytokinetics Announces Additional Data from ACACIA-HCM Presented at the HFSA Annual Scientific Meeting 2026 GlobeNewswire·Oct 12, 2026

Outperform Recommendation Issued On CYTK By RBC Capital KlickAnalytics·Oct 8, 2026 Statement of changes in beneficial ownership of securities - Form 4 SEC Filings (All years)·Oct 6, 2026 Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026 GlobeNewswire·Oct 2, 2026 Lexicon Pharmaceuticals: Upgrading On Sotagliflozin HCM Data In Q1 '27 And More SeekingAlpha·Sep 30, 2026 Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy GlobeNewswire·Sep 30, 2026

About Cytokinetics (CYTK) Stock

Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction. Cytokinetics' MYQORZO® ( aficamten ) is a cardiac myosin inhibitor approved in the U.S., China, EU and UK for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Following positive topline results in ACACIA-HCM, a Phase 3 clinical trial of aficamten in patients with non-obstructive HCM (nHCM), the company plans to discuss the results with the U.S. FDA and other regulatory authorities.

Trade U.S. Stocks with trader2B

FREE $100K ToroChallenge®

Learn more →

FREE $100K trading rules

Learn more →

Eligible U.S. stocks & ETFs

Learn more →

trader2B trading platform

Learn more →

Compare ToroChallenge® funded plans

Learn more →

Cytokinetics Incorporated Stock Insights

View More Blog →

Uncategorized Quick-Hit Sessions bei 1Red Casino: Schnelle Runden, Klare Entscheidungen, Soforter Spaß

Einige Spieler bevorzugen es, sich auf lange Sicht einzurichten. Andere nicht. Wenn Sie der Typ...

Read article → Uncategorized Mostbet Azərbaycan – platformaya ümumi baxış

Mostbet Azərbaycan – platformaya ümumi baxış ▶️ OYNA Содержимое Qeydiyyat və hesabın yaradılması Bonus və...

Read article → Uncategorized Mostbet Azərbaycan – oyunlar və imkanlar

Mostbet Azərbaycan – oyunlar və imkanlar ▶️ OYNA Содержимое Qeydiyyat və hesab açma prosesi Depozit...

Read article →

Explore other popular U.S. stocks.

View all stocks →

Frequently Asked Questions About CYTK Trading

FREE $100K account, trading rules, payouts, hours and algo trading.

What should traders know before trading CYTK?

Cytokinetics (CYTK) trading conditions on the NGS can vary significantly due to shifting daily volume and bid-ask spreads. Technical day traders often evaluate real-time order book liquidity and key chart levels, such as its 200-day moving average of $$69.20, before executing a trade.

What are the rules for day trading CYTK on a funded account?

Stocks must be included on the eligible symbol list to be traded in the FREE $100K ToroChallenge®. For approved U.S. equities, regular market hours are 9:30 AM to 4:00 PM New York time. Under the trading rules, all positions must be closed before the end of the trading session; overnight holding is not permitted.

How do I qualify to trade Cytokinetics Incorporated (CYTK) and what is the profit split?

You can start trader2B^® FREE $100K evaluation with no upfront cost or credit card required. After meeting the performance requirements and passing the evaluation, you can receive a live funded account with a 50% profit split. Traders who want higher payout percentages can choose paid Funded Trader Pricing – ToroChallenge® Plans | trader2B® offering up to 95%–99% profit splits. Symbol availability depends on the eligible symbol list for each program.

Can I use algorithms or API bots to trade CYTK?

Trading Cytokinetics Incorporated (CYTK) requires the stock to be on our active eligible symbol list. For all approved equities, standard execution on the FREE $100K ToroChallenge® is manual. If you want to deploy automated bots, algorithmic strategies, or custom scripts, you can unlock API trading as an optional premium feature. Manage your keys and enable API access directly through the Trader2B add-ons page.

Why are some U.S. stocks not available to trade on trader2B^®?

trader2B^® limits its eligible symbol list based on liquidity, price, short-sale availability, risk, and overall market quality. Stocks with low trading volume, very low prices, wide bid-ask spreads, limited short availability, or elevated manipulation risk may be excluded from the FREE $100K ToroChallenge^®. You can view the current list of approved stocks on the eligible symbol list

How and when can I withdraw profits after trading CYTK on a funded account?

After passing the evaluation and being approved for a live funded account, you can request payouts based on the profit split and withdrawal rules for your program. Payout eligibility depends on maintaining the required risk limits and following the funded account rules. For current payout terms and withdrawal requirements, please review the trading rules.

What platforms can I use to trade CYTK with trader2B^®?

trader2B^® WebTrader: A fast, browser-based platform requiring zero software downloads.
trader2B^® Desktop: A high-performance downloadable application for Windows, macOS, and Linux, equipped with multi-monitor support, Level II data, and hotkey execution.
trader2B^® Mobile App: Mobile trading available on both iOS (App Store) and Android (Google Play) to monitor and manage open positions on the go.
API Trading: Automated execution and custom algorithmic trading enabled via the optional trader2B^® API add-on

How much buying power do I get to trade CYTK?

Traders starting the FREE $100K ToroChallenge^® are allocated up to $100,000 in intraday buying power to trade eligible U.S. equities, including Cytokinetics Incorporated (CYTK). For traders seeking greater capital scaling, our advanced paid tiers provide up to $250,000 in total buying power with flexible account reset options. You can compare all available capital allocations and upgrade paths directly on our plans page.

Can I get a higher profit split than the FREE $100K Challenge?

Yes. Traders who want a higher potential profit split can choose a paid ToroChallenge® plan: Toro25 up to 95%, Toro100 up to 97%, and Toro250 up to 99%. Compare ToroChallenge® plans.

Can I use algo orders or automated trading to trade CYTK?

The FREE $100K ToroChallenge® does not permit bots, API trading, or automated/algo trading strategies. Algo or API availability on other ToroChallenge® programs depends on the specific plan, platform and applicable rules.

Ready to trade Cytokinetics stock with trader2B® capital?

Start the FREE $100K ToroChallenge® and trade eligible U.S. stocks including CYTK.

Start FREE $100K Challenge →

100% FREE · No credit card · Day trading

Trade Cytokinetics (CYTK) with a $100K Funded Account

Cytokinetics Financial Highlights

Latest Cytokinetics (CYTK) Stock News

About Cytokinetics (CYTK) Stock

Trade U.S. Stocks with trader2B

Cytokinetics Incorporated Stock Insights

Related Stocks

Frequently Asked Questions About CYTK Trading

What should traders know before trading CYTK?

What are the rules for day trading CYTK on a funded account?

How do I qualify to trade Cytokinetics Incorporated (CYTK) and what is the profit split?

Can I use algorithms or API bots to trade CYTK?

Why are some U.S. stocks not available to trade on trader2B®?

How and when can I withdraw profits after trading CYTK on a funded account?

What platforms can I use to trade CYTK with trader2B®?

How much buying power do I get to trade CYTK?

Can I get a higher profit split than the FREE $100K Challenge?

Can I use algo orders or automated trading to trade CYTK?

Ready to trade Cytokinetics stock with trader2B® capital?

Why are some U.S. stocks not available to trade on trader2B^®?

What platforms can I use to trade CYTK with trader2B^®?